Project ECHO, which helps specialists disseminate knowledge to primary care providers, was created on the idea that patients should not be dying from curable diseases because they don’t have access to the right providers, said Sanjeev Arora, MD, FACG, MACP, director and founder of Project ECHO and a professor of medicine at University of New Mexico.
Project ECHO, which helps specialists disseminate knowledge to primary care providers, was created on the idea that patients should not be dying from curable diseases because they don’t have access to the right providers, said Sanjeev Arora, MD, FACG, MACP, director and founder of Project ECHO and a professor of medicine at University of New Mexico.
Transcript
As the founder of Project ECHO, can you explain when this program was started, what population it serves, and what inspired you to create it?
I’m a hepatitis C specialist and I was treating hepatitis C at the University of New Mexico in my clinic, and I recall a patient who she was a 43-year-old woman and she came to see me and there was an 8-month wait to see me in my clinic, and people were driving hundreds of miles to see me. Two hundred miles each way. And would have to make 12 to 18 trips to get treatment, because treatment involved weekly injections with interferon and another medicine that caused anemia, called ribavirin. When she saw me, she had 2 children—1 was a son, 14 years old, she had a daughter who was 9—and she wanted treatment for hepatitis C. She had been diagnosed with hepatitis C many years ago. Her husband had passed away in a car accident 5 years earlier, so she was a single mother.
And when I saw her, she had cancer of the liver already, which was the size of a baseball. And she really wanted to live because she had 2 children, but there was nothing we could do, and she died of a disease that is actually quite curable, because there were no doctors in her area that had the ability or knowledge to treat hepatitis C.
And over the years, I’ve had more than a hundred patients like that, who died of hepatitis C-related liver cancer when this was totally preventable, and because of the 8-month wait and the long drives, poor people couldn’t access me, and I thought I had to do something else to bring access to care to everyone in New Mexico who had this disease, so more people didn’t die of liver failure and liver cancers. And that’s how I started Project ECHO, to bring access to care for hepatitis C treatment to everyone, and then I knew if I could do that, I would have a model for complex diseases and rural locations and other countries.
Perioperative Nivolumab Boosts NSCLC Survival: CheckMate 77T Trial
May 16th 2024This interim analysis of the CheckMate 77T trial, outcomes were compared between adult patients receiving neoadjuvant nivolumab plus chemotherapy or neoadjuvant chemotherapy plus placebo for resectable non–small cell lung cancer (NSCLC).
Read More
Decitabine, Venetoclax Combo Boosts Survival in Patients With AML and MDS
May 16th 2024Study findings demonstrate that combining decitabine with venetoclax enhances molecular response rates in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), correlating strongly with improved clinical outcomes and overall survival.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
Atypical Marker Expression in T-Cell Acute Lymphoblastic Leukemia/Lymphoma
May 15th 2024Two unique case reports highlight the diagnostic challenges and critical importance of comprehensive immunophenotyping in cases of T-cell acute lymphoblastic leukemia/lymphoma that present without typical immaturity markers but with rare γδ T-cell receptor expression.
Read More
After the ACA Expanded Health Care Access, 2024 Elections May See Voters Demand Affordability
May 15th 2024At the spring conference of the New Jersey Health Care Quality Institute, speakers discussed how health policy, affordability, and transparency may play a role in voters’ decisions.
Read More